Premal H. Patel - Concepedia

Author

Premal H. Patel

University of Washington

Also Known As

P H Patel, P. H. Patel, P. Patel, P.H. Patel, PREMAL PATEL, Premal H Patel, Premal H. Patel, Premal Patel, Princy Patel

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

University of Washington Memorial Sloan Kettering Cancer Center Tennessee Oncology Institute of Cancer Research INCLIVA Health Research Institute

About

Premal H. Patel is an author at University of Washington specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	966
2	Natural Sciences	2	2	226
3	Engineering	1	1	51
4	Biomolecular Engineering	1	1	142
5	Biostatistics	1	1	51

Premal H. Patel

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer David R. Spigel, Thomas J. Ervin, Rodryg Ramlau, Journal of Clinical Oncology	2013	474
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss Johann S. de Bono, Ugo De Giorgi, Daniel Nava Rodrigues, Clinical Cancer Research	2018	303
Final efficacy results from OAM4558g, a randomized phase II study evaluating MetMAb or placebo in combination with erlotinib in advanced NSCLC. David R. Spigel, Thomas J. Ervin, Rodryg Ramlau, Journal of Clinical Oncology Advanced NsclcFinal Efficacy ResultsOncologyClinical TherapeuticMetronomic Therapy	2011	194
Phase I Study Combining Treatment with Temsirolimus and Sunitinib Malate in Patients with Advanced Renal Cell Carcinoma Premal H. Patel, P. Senico, Rafael E. Curiel, Clinical Genitourinary Cancer UrologySurgical OncologySunitinib MalateGenitourinary CancerMedicine	2009	167
A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors Cristina Saura, Desamparados Roda, Susana Roselló, Cancer Discovery	2016	167
Insights into DNA Polymerization Mechanisms from Structure and Function Analysis of HIV-1 Reverse Transcriptase Premal H. Patel, Alfredo Jacobo‐Molina, Jianping Ding, Biochemistry	1995	163
Targeted therapy for metastatic renal cell carcinoma Premal H. Patel, R.S.K. Chaganti, Robert J. Motzer British Journal of Cancer UrologyGenitourinary CancerMedicineCancer TreatmentOncology	2006	150
Marked infidelity of human immunodeficiency virus type 1 reverse transcriptase at RNA and DNA template ends. Premal H. Patel, B D Preston Proceedings of the National Academy of Sciences Viral ReplicationViral Polymerase MechanismImmunologyMarked InfidelityMolecular Biology	1994	142
Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit Hartmut Koeppen, Wei Yu, Jiping Zha, Clinical Cancer Research	2014	131
DNA polymerase active site is highly mutable: Evolutionary consequences Premal H. Patel, Lawrence A. Loeb Proceedings of the National Academy of Sciences	2000	116

Page 1